Latest Breaking News On - ஆண்ட்ரூ சொல்தான் - Page 1 : comparemela.com

Israeli company Sight Diagnostic’s Sight OLO blood diagnostics device. Photo: Sight Diagnostics via Facebook. CTech – Sight Diagnostics, an Israeli company that delivers lab-grade Full Blood Count (FBC) results in just a few minutes, has deployed its Sight OLO solution at the John Radcliffe Hospital, part of Oxford University Hospitals NHS Foundation. The deployment means that patients who attend the emergency departments have access to quick FBC testing as part of a rapid AI triage system for Covid-19. Sight OLO helps with faster predictions to be made by CURIAL AI, a screening test developed by Oxford University that leverages the routine vital signs of patients alongside FBC results to determine the likelihood of a patient having Covid-19. The CURIAL algorithm was developed by Oxford University and has proven to be effective in ruling out the possibility of Covid-19 within patients in the first hour, as opposed to the 12-28 hour timeframe offered by Polymerase Chain Reaction

United statesUnited kingdomAndrew soltanYossi pollakOxford university hospitalsOxford universityMachine learning researcher at oxford universitySight diagnosticSight diagnosticsFull blood countJohn radcliffe hospitalPolymerase chain reactionAcademic clinicianMachine learning researcherComplete blood countஒன்றுபட்டது மாநிலங்களில்